Terapia fotodinâmica como adjuvante no tratamento da doença periodontal em equinos / [Adjunctive photodynamic therapy as a treatment for periodontal disease in equines]

A doença periodontal é uma afecção comum, relacionada ao aprisionamento de alimentos em diastemas não fisiológicos, em equinos. O tratamento consiste na correção da causa primária, limpeza e desbridamento do sulco gengival, denominado tratamento convencional (TC). Frequentemente antimicrobianos são necessários, pela gravidade ou patogenicidade dos agentes. A terapia fotodinâmica adjuvante (TF) tem sido estudada pelo seu potencial combate bacteriano, sem causar resistência bacteriana. O objetivo deste estudo foi analisar o uso da TF na doença periodontal, experimentalmente induzida, em dentes incisivos de equinos, e compará-la com o TC. O TC não resultou em melhora clínica estatisticamente, tanto em graus como em profundidade, apenas numérica na profundidade aos 30 dias. A TF foi empregada em dentes com profundidade maior da bolsa periodontal que a do grupo TC e, mesmo assim, apresentou melhora clínica já com sete dias, e mais efetiva aos 30, atingindo, em média, o valor considerado normal, três milímetros. A TF apresentou potencial para ser aplicada na rotina, pelo incremento nos resultados, sem causar efeitos colaterais.(AU)

Periodontal disease is a common condition, related to the entrapment of food in non-physiological diastemas in horses. Treatment consists of correction of the primary cause, cleansing and debridement of the gingival sulcus, called Conventional Therapy (CT). Often antimicrobials are requested due to the severity or pathogenicity of the agents. Adjuvant Photodynamic Therapy (PDT), has been studied for its potential bacterial combat, without causing bacterial resistance. The objective of this study was to analyze the use PDT with the experimentally induced periodontal disease in the incisor teeth of horses, and to compare with the CT. The CT did not result in clinical improvement, either in degrees or millimeters. The PDT was used in teeth with a greater depth of the periodontal pocket than the TC group, and even then, showed clinical improvement in only seven days, and more effective at 30, reaching the three millimeter value considered normal on average. The PDT presented the potential to be applied in the routine by the increase in the results without causing side effects.(AU)

Uso da terapia fotodinâmica empregando azul de metileno a 2% como agente fotossensibilizante para o controle de crescimento tumoral em calopsita (Nynphicus hollandicus) portador de sarcoma / Use of photodynamic therapy using methylene blue 2% as photosensitizing agent to control tumor growthin a cockatiel (Nynphicus hollandicus) carrier sarcoma

Os sarcomas são neoplasias de origem mesenquimal. Os sarcomas são neoplasias de origem mesenquimal, sendo considerados tumores agressivos que frequentemente gerammetástases e rápida debilidade. A indicação terapêutica é a exérese tumoral enquanto ainda não houver metástases. A terapiafotodinâmica tem sido utilizada para o tratamento de neoplasias tanto em humanos quanto em animais e muitos estudos têm sidodesenvolvidos de maneira a aprimorar e avaliar a efetividade da técnica. Uma calopsita (Nynphycus hollandicus) foi levada paraatendimento no Hospital Veterinário Professor Firmino Mársico Filho (HUVET-UFF) apresentando nódulo em região escapuloumeral.O diagnóstico citopatológico concluiu sarcoma. Devido à localização e impossibilidade de exérese cirúrgica, optou-sepela realização da terapia fotodinâmica utilizando-se o azul de metileno a 2% como agente fotossensibilizador e fonte de luz laserdiodo (Vetlight®). A terapia fotodinâmica empregando o azul de metileno como agente fotossensibilizante foi eficaz no controle docrescimento tumoral até os 30 dias posteriores observados.

Sarcoma are tumors of mesenchymal origin. They are aggressive tumors that frequently metastasize and rapid weakness. Thetherapeutic indication is the resection while there is still no metastasis. Photodynamic therapy has been used for the treatment ofcancer in both humans and animals and many studies have been developed in order to improve and enhance the effectivenessof the techniques. A Nynphycus hollandicus was brought to HUVET-UFF clinical service presenting a lump in scapulohumeralregion. The citological exam had a diagnosis of sarcoma. Due to its location and inability to surgical excision, was decided bythe completion of photodynamic therapy using methylene blue at 2% as a phosensitizing agent and laser diode light source(Vetlight®). Photodynamic therapy using methylene blue as photosensitizing agent was effective in controlling growth up to 30days later observed.

Photodynamic hyperthermal chemotherapy with indocyanine green: a novel cancer therapy for 16 cases of malignant soft tissue sarcoma

Sixteen cases of malignant soft tissue sarcoma (STS; 10 canines and six felines) were treated with a novel triple therapy that combined photodynamic therapy, hyperthermia using indocyanine green with a broadband light source, and local chemotherapy after surgical tumor resection. This triple therapy was called photodynamic hyperthermal chemotherapy (PHCT). In all cases, the surgical margin was insufficient. In one feline case, PHCT was performed without surgical resection. PHCT was performed over an interval of 1 to 2 weeks and was repeated three to 21 times. No severe side effects, including severe skin burns, necrosis, or skin suture rupture, were observed in any of the animals. No disease recurrence was observed in seven out of 10 (70.0%) dogs and three out of six (50.0%) cats over the follow-up periods ranging from 238 to 1901 days. These results suggest that PHCT decreases the risk of STS recurrence. PHCT should therefore be considered an adjuvant therapy for treating companion animals with STS in veterinary medicine.